Crossmark

Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson’s disease

Published Online: 2019-10-23

Published Print: 2020-08

Authors

Yonguc, Tarik https://orcid.org/0000-0002-2131-0812
Sefik, Ertugrul https://orcid.org/0000-0002-7514-7133
Inci, Ipek https://orcid.org/0000-0002-2660-0720
Kusbeci, Ozge Yılmaz https://orcid.org/0000-0002-4048-210X
Celik, Serdar https://orcid.org/0000-0003-0939-9989
Aydın, Mehmet Erhan https://orcid.org/0000-0002-3354-5352
Polat, Salih https://orcid.org/0000-0002-7580-6872
License Information

Text and Data Mining valid from 2019-10-23

Version of Record valid from 2019-10-23
More Information

Article History

Received: 11 March 2019

Accepted: 4 October 2019

First Online: 23 October 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current